Is GHK-Cu Legal in the UK and UAE?
GHK-Cu (copper peptide) is not a controlled substance in the UK and is lawful to buy as a research reagent; it has no MHRA marketing authorisation for topical, cosmetic, or medicinal human use.
GHK-Cu is not scheduled as a controlled substance in the UAE and is supplied research-use-only, separate from any DHA/MOHAP-licensed cosmetic or clinical product containing copper peptides.
UK detail
GHK-Cu is widely present in licensed cosmetic formulations at controlled concentrations, which sometimes causes confusion about the raw research compound's status. Sold as a research reagent — unformulated, no carrier, no cosmetic claims — it sits outside medicines regulation the same way the other compounds on this page do: lawful to purchase for research, not lawful for a supplier to market for skin, hair, or wound-healing outcomes without the relevant cosmetic-product or medicines authorisation.
UAE detail
GHK-Cu is not scheduled in the UAE. As a raw research reagent it is distinct from finished cosmetic products containing copper peptides, which are regulated separately under UAE cosmetics rules.
This is a general overview, not legal advice, and law in this area can change. For a specific situation, consult a solicitor with life-sciences regulatory experience (UK) or MOHAP/DHA directly (UAE). See our full UK compliance guide and UAE compliance guide for the full legal framework this page summarises.